Pigmented basal cell carcinoma successfully treated with 5% Imiquimod cream.
Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histological clearance rates of up to 100%. We report our experience of treatment a large pigmented BCC on the face with topical Imiquimod 5% cream.
Mehta
Vandana
V
Department of Skin and STD, Kasturba Medical College, Manipal, Karnataka, India. vandanamht@yahoo.com
Balachandran
C
C